Biocon Ltd. NSE: BIOCON | BSE: 532523

Mid-range Performer

Download real time

363.70 6.85 (1.92%)

2.5M

NSE+BSE Volume

NSE 05 Sep, 2025 3:31 PM (IST)

US FDA Observation

Biocon gets Form 483 with 5 observations from the US FDA for its Bengaluru drug substance facility See details

Biocon Ltd. News and Updates

Name: Latest research reports of Biocon Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Biocon Ltd.
Rating: 5
Author: Axis Direct

Keep track of all breaking news on Biocon Ltd. from all sources in a single place.

Load latest

Is Biocon Ltd. worth buying?

726 Votes:

Buy 74.93%

Sell 16.39%

Hold 8.68%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Sell SEE REPORTS >

pdf